NeutriSci International Inc.

NU

CA64129Y1079

Food Processing

Market Closed - Toronto S.E. Other stock markets 10:00:03 2024-04-24 am EDT			5-day change	1st Jan Change
0.005 ^CAD	0.00%		0.00%	0.00%

2023	NeutriSci International Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
2023	NeutriSci International Inc. Announces Board of Director Changes	CI

Neutrisci International Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020

August 27, 2020 at 07:56 pm EDT

NeutriSci International Inc. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced sales was CAD 4,831 compared to CAD 14,176 a year ago. Net loss was CAD 354,829 compared to CAD 436,249 a year ago. For the half year, sales was CAD 8,154 compared to CAD 59,441 a year ago. Net loss was CAD 772,069 compared to CAD 982,619 a year ago. Basic loss per share was CAD 0.01 compared to CAD 0.01 a year ago.

Latest news about NeutriSci International Inc.

NeutriSci International Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 24	CI
NeutriSci International Inc. Announces Board of Director Changes	23-10-20	CI
NeutriSci International Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-18	CI
NeutriSci International Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-25	CI
NeutriSci International Inc. Provides Update to Product Arrangement with Gaia Grow Corp	23-05-12	CI
NeutriSci International Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-05-01	CI
NeutriSci International Inc. Auditor Raises 'Going Concern' Doubt	23-04-30	CI
NeutriSci International Inc. announced that it has received CAD 0.196774 million in funding	22-12-29	CI
NeutriSci International Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-29	CI
NeutriSci International Inc. announced that it expects to receive CAD 0.25 million in funding	22-11-22	CI
NeutriSci International Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-26	CI
NeutriSci Announces Distribution Start of neuenergy in Europe	22-07-25	CI
NeutriSci Shipped Order to Tabletz Distribution Partner; Up 25.8% in Early Frankfurt Trading	22-06-07	MT
NeutriSci International Inc. Ships Order to Tabletz Distribution Partner	22-06-07	CI
NeutriSci International Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-27	CI
NeutriSci International Inc. Auditor Raises 'Going Concern' Doubt	22-05-01	CI
NeutriSci International Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-05-01	CI
NeutriSci International Says it Shipped Products to Distributors in Japan and Canada	22-02-03	MT
NeutriSci International to Delist its Shares From the OTCQB Market	22-01-26	MT
NeutriSci International Says Ships Order to Japan	22-01-18	MT
NeutriSci International Inc. Ships Tabletz Order to Japan	22-01-18	CI
NeutriSci Signs Exclusive 5-Year Distribution Pact For Europe, Secures Initial Order; Soars 37.2% in Frankfurt Trading	22-01-04	MT
NeutriSi International Inc. Announces that it Has Executed a Definitive Agreement with TH International Consulting GmbH for the Distribution of Neuenergy in Europe	22-01-04	CI
NeutriSci International Inc. Completes R&D of Effervescent Functional Mushroom Tablet	21-11-30	CI
NeutriSci International Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-22	CI

Chart NeutriSci International Inc.

Duration

Period

More charts

Company Profile

NeutriSci International Inc. (NeutriSci) is a Canada-based company, which specializes in the development, formulation, and production of products for its business-to-business (B2B) partners around the globe. The Company is focused on the market development for its nutraceutical products. Its products utilize patented form of Pterostilbene called pTeroPure. pTeroPure Pterostilbene is a form of all-trans Pterostilbene that is found naturally in blueberries and is manufactured for NeutriSci by ChromaDex Corp. (ChromaDex) in the United States. NeutriSciâs neuenergy product is an energy tab designed to deliver enhanced focus and mental clarity with no sugar, no calories and no crash that is associated with energy products. It has developed proprietary IP and technology (NeutriSci IP) that creates an efficient method of bilingual absorption of nutraceuticals into the bloodstream. NeutriSciâs IP can be applied to many different categories in the beverage, food, and nutraceutical space.

Sector

Food Processing

Calendar

2024-04-28 - Q4 2023 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Special Foods & Wellbeing Products

	1st Jan change	Capi.
NEUTRISCI INTERNATIONAL INC.	0.00%	653K
ZHEJIANG NHU COMPANY LTD.	+6.96%	7.59B
CSPC INNOVATION PHARMACEUTICAL CO., LTD.	+5.49%	5.93B
BYHEALTH CO., LTD	-8.63%	3.66B
THE SIMPLY GOOD FOODS COMPANY	-13.28%	3.38B
XIAMEN KINGDOMWAY GROUP COMPANY	-15.49%	1.16B
SIRIO PHARMA CO., LTD.	+10.65%	979M
HERBALIFE LTD.	-39.71%	922M
USANA HEALTH SCIENCES, INC.	-18.47%	861M
JAMIESON WELLNESS INC.	-17.52%	800M